Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Gachet

Showing results (121-130 of 210) with videos related to

Pageof 21
Sort By:
JACC. Cardiovascular Interventions|July 16, 2010
Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registrySoraya El Ghannudi, Patrick Ohlmann, Nicolas Meyer, et al.
Thrombosis and Haemostasis|October 9, 2008
Plasma levels of soluble platelet glycoprotein V are linked to fasting blood glucose in patients with type 2 diabetesBoris Aleil, Laurence Kessler, Nicolas Meyer, et al.
Blood Advances|September 14, 2021
Platelet FcγRIIA-induced serotonin release exacerbates the severity of transfusion-related acute lung injury in miceMarie-Belle El Mdawar, Blandine Maître, Stéphanie Magnenat, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 2012
Association of estimated GFR with platelet inhibition in patients treated with clopidogrelClotilde Muller, Sophie Caillard, Laurence Jesel, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2005
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt]Béatrice Hechler, Stéphanie Magnenat, Maddalena L Zighetti, et al.
Thrombosis Research|March 12, 2016
Standardization of a well-controlled in vivo mouse model of thrombus formation induced by mechanical injuryChaojun Tang, Yinyan Wang, Daoxi Lei, et al.
Nuclear Medicine and Biology|April 7, 2018
Imaging thrombosis with <sup>99m</sup>Tc-labeled RAM.1-antibody in vivoAli Ouadi, Virgile Bekaert, Nicolas Receveur, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 19, 2018
Neuroprotective effects of microglial P2Y<sub>1</sub> receptors against ischemic neuronal injuryYuichiro Fukumoto, Kenji F Tanaka, Bijay Parajuli, et al.
Journal of the American College of Cardiology|March 13, 2010
A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaquesArmin J Reininger, Isabell Bernlochner, Sandra M Penz, et al.
Journal of the American Society of Nephrology : JASN|January 12, 2007
P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritisBernd Hohenstein, Sindy Renk, Kathrin Lang, et al.
Pageof 21

Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
JACC. Cardiovascular Interventions|July 16, 2010
Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registrySoraya El Ghannudi, Patrick Ohlmann, Nicolas Meyer, et al.
Thrombosis and Haemostasis|October 9, 2008
Plasma levels of soluble platelet glycoprotein V are linked to fasting blood glucose in patients with type 2 diabetesBoris Aleil, Laurence Kessler, Nicolas Meyer, et al.
Blood Advances|September 14, 2021
Platelet FcγRIIA-induced serotonin release exacerbates the severity of transfusion-related acute lung injury in miceMarie-Belle El Mdawar, Blandine Maître, Stéphanie Magnenat, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 2012
Association of estimated GFR with platelet inhibition in patients treated with clopidogrelClotilde Muller, Sophie Caillard, Laurence Jesel, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2005
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt]Béatrice Hechler, Stéphanie Magnenat, Maddalena L Zighetti, et al.
Thrombosis Research|March 12, 2016
Standardization of a well-controlled in vivo mouse model of thrombus formation induced by mechanical injuryChaojun Tang, Yinyan Wang, Daoxi Lei, et al.
Nuclear Medicine and Biology|April 7, 2018
Imaging thrombosis with <sup>99m</sup>Tc-labeled RAM.1-antibody in vivoAli Ouadi, Virgile Bekaert, Nicolas Receveur, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 19, 2018
Neuroprotective effects of microglial P2Y<sub>1</sub> receptors against ischemic neuronal injuryYuichiro Fukumoto, Kenji F Tanaka, Bijay Parajuli, et al.
Journal of the American College of Cardiology|March 13, 2010
A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaquesArmin J Reininger, Isabell Bernlochner, Sandra M Penz, et al.
Journal of the American Society of Nephrology : JASN|January 12, 2007
P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritisBernd Hohenstein, Sindy Renk, Kathrin Lang, et al.
Pageof 21